Literature DB >> 7723769

Spontaneous and cycloheximide-induced interleukin-10 mRNA expression in human mononuclear cells.

P Stordeur1, L Schandené, P Durez, C Gérard, M Goldman, T Velu.   

Abstract

Interleukin-10 (IL-10) is known to be spontaneously produced by human peripheral blood mononuclear cells. In order to define the cell type in which IL-10 gene is spontaneously expressed we used the reverse polymerase chain reaction for IL-10 mRNA expression, which was also used to study the effects of cycloheximide (CHX). First, we found that IL-10 mRNA is spontaneously expressed in monocytes and B cells but not T cells from healthy donors, and second, we demonstrated that CHX superinduces IL-10 mRNA in monocytes and B cells. Experiments including nuclear run-on analyses established that the effects of CHX on IL-10 gene expression involve both gene transcription and mRNA stabilization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7723769     DOI: 10.1016/0161-5890(94)00158-w

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

1.  De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.

Authors:  Jianjiang Ye; Lyndle Gradoville; Derek Daigle; George Miller
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

2.  T cells of the human intestinal lamina propria are high producers of interleukin-10.

Authors:  J Braunstein; L Qiao; F Autschbach; G Schürmann; S Meuer
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

3.  T cell proliferation, MHC class II restriction and cytokine products of gliadin-stimulated peripheral blood mononuclear cells (PBMC).

Authors:  J O'Keeffe; K Mills; J Jackson; C Feighery
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

4.  In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease.

Authors:  F Autschbach; J Braunstein; B Helmke; I Zuna; G Schürmann; Z I Niemir; R Wallich; H F Otto; S C Meuer
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

5.  Incompatibility of chemical protein synthesis inhibitors with accurate measurement of extended protein degradation rates.

Authors:  Christina Chan; Philip Martin; Neill J Liptrott; Marco Siccardi; Lisa Almond; Andrew Owen
Journal:  Pharmacol Res Perspect       Date:  2017-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.